Search alternatives:
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
5081
-
5082
-
5083
Image 1_The frequency of mutations in the penA, mtrR, gyrA and parC genes of Neisseria gonorrhoeae, the presence of tetM gene and antibiotic resistance/susceptibility: a systematic...
Published 2025“…More than 50% of azithromycin-resistant isolates had mutations in the mtrR gene, while more than 50% of ciprofloxacin-resistant and intermediate-resistant isolates had mutations in gyrA. …”
-
5084
Data Sheet 1_The frequency of mutations in the penA, mtrR, gyrA and parC genes of Neisseria gonorrhoeae, the presence of tetM gene and antibiotic resistance/susceptibility: a syste...
Published 2025“…More than 50% of azithromycin-resistant isolates had mutations in the mtrR gene, while more than 50% of ciprofloxacin-resistant and intermediate-resistant isolates had mutations in gyrA. …”
-
5085
-
5086
-
5087
-
5088
-
5089
-
5090
-
5091
-
5092
-
5093
Synthesis, Biological Evaluation, Structure–Activity Relationship, and Mechanism of Action Studies of Quinoline–Metronidazole Derivatives Against Experimental Visceral Leishmaniasi...
Published 2019“…In our efforts to identify novel chemical scaffolds for the development of antileishmanial agents, a series of quinoline–metronidazole hybrid compounds was synthesized and tested against the murine model of visceral leishmaniasis. …”
-
5094
-
5095
-
5096
-
5097
-
5098
-
5099
-
5100